Cargando…

Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp

INTRODUCTION: Increased postprandial glucose (PPG) is associated with high glycated haemoglobin levels and is an independent risk factor for cardiovascular diseases. The aim of this study was to compare PPG increments in Asian versus non-Asian adults with type 2 diabetes (T2D), who were insulin-naïv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenying, Akhtar, Shahid, Franek, Edward, Haluzík, Martin, Hirose, Takahisa, Kalyanam, Balamurali, Kar, Soumitra, Wu, Ted, Gogas Yavuz, Dilek, Unnikrishnan, Ambika Gopalakrishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873325/
https://www.ncbi.nlm.nih.gov/pubmed/35044568
http://dx.doi.org/10.1007/s13300-021-01196-7
_version_ 1784657439601197056
author Yang, Wenying
Akhtar, Shahid
Franek, Edward
Haluzík, Martin
Hirose, Takahisa
Kalyanam, Balamurali
Kar, Soumitra
Wu, Ted
Gogas Yavuz, Dilek
Unnikrishnan, Ambika Gopalakrishnan
author_facet Yang, Wenying
Akhtar, Shahid
Franek, Edward
Haluzík, Martin
Hirose, Takahisa
Kalyanam, Balamurali
Kar, Soumitra
Wu, Ted
Gogas Yavuz, Dilek
Unnikrishnan, Ambika Gopalakrishnan
author_sort Yang, Wenying
collection PubMed
description INTRODUCTION: Increased postprandial glucose (PPG) is associated with high glycated haemoglobin levels and is an independent risk factor for cardiovascular diseases. The aim of this study was to compare PPG increments in Asian versus non-Asian adults with type 2 diabetes (T2D), who were insulin-naïve or insulin-experienced, from the phase 3 insulin degludec/insulin aspart (IDegAsp) clinical trials. METHODS: This was a post hoc analysis of data from 13 phase 3, randomised, parallel-group, open-label IDegAsp trials in patients with T2D. The pooled baseline clinical data were analysed for insulin-naïve and insulin-experienced groups; and each group was split into subgroups of Asian and non-Asian patients, respectively, and analysed accordingly. Baseline self-monitored blood glucose (SMBG) values at breakfast, lunch and the evening meal (before and 90 min after each meal) were used to assess PPG increments. The estimated differences in baseline SMBG increment between the Asian and non-Asian subgroups were analysed. RESULTS: Clinical data from 4750 participants (insulin-naïve, n = 1495; insulin-experienced, n = 3255) were evaluated. In the insulin-naïve group, the postprandial SMBG increment was significantly greater in the Asian versus the non-Asian subgroup at breakfast (estimated difference 28.67 mg/dL, 95% confidence interval [CI] 18.35, 38.99; p < 0.0001), lunch (17.34 mg/dL, 95% CI 6.47, 28.21; p = 0.0018) and the evening meal (16.19 mg/dL, 95% CI 5.04, 27.34; p = 0.0045). In the insulin-experienced group, the postprandial SMBG increment was significantly greater in the Asian versus non-Asian subgroup at breakfast (estimated difference 13.81 mg/dL, 95% CI 9.19, 18.44; p < 0.0001) and lunch (29.18 mg/dL, 95% CI 24.22, 34.14; p < 0.0001), but not significantly different at the evening meal. CONCLUSION: In this post hoc analysis, baseline PPG increments were significantly greater in Asian participants with T2D than in their non-Asian counterparts at all mealtimes, with the exception of the evening meal in insulin-experienced participants. Asian adults with T2D may benefit from the use of regimens that control PPG excursions. CLINICAL TRIAL NUMBERS: NCT02762578, NCT01814137, NCT01513590, NCT01009580, NCT01713530, NCT02648217, NCT01045447, NCT01365507, NCT01045707, NCT01272193, NCT01059812, NCT01680341, NCT02906917. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13300-021-01196-7.
format Online
Article
Text
id pubmed-8873325
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-88733252022-03-02 Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp Yang, Wenying Akhtar, Shahid Franek, Edward Haluzík, Martin Hirose, Takahisa Kalyanam, Balamurali Kar, Soumitra Wu, Ted Gogas Yavuz, Dilek Unnikrishnan, Ambika Gopalakrishnan Diabetes Ther Original Research INTRODUCTION: Increased postprandial glucose (PPG) is associated with high glycated haemoglobin levels and is an independent risk factor for cardiovascular diseases. The aim of this study was to compare PPG increments in Asian versus non-Asian adults with type 2 diabetes (T2D), who were insulin-naïve or insulin-experienced, from the phase 3 insulin degludec/insulin aspart (IDegAsp) clinical trials. METHODS: This was a post hoc analysis of data from 13 phase 3, randomised, parallel-group, open-label IDegAsp trials in patients with T2D. The pooled baseline clinical data were analysed for insulin-naïve and insulin-experienced groups; and each group was split into subgroups of Asian and non-Asian patients, respectively, and analysed accordingly. Baseline self-monitored blood glucose (SMBG) values at breakfast, lunch and the evening meal (before and 90 min after each meal) were used to assess PPG increments. The estimated differences in baseline SMBG increment between the Asian and non-Asian subgroups were analysed. RESULTS: Clinical data from 4750 participants (insulin-naïve, n = 1495; insulin-experienced, n = 3255) were evaluated. In the insulin-naïve group, the postprandial SMBG increment was significantly greater in the Asian versus the non-Asian subgroup at breakfast (estimated difference 28.67 mg/dL, 95% confidence interval [CI] 18.35, 38.99; p < 0.0001), lunch (17.34 mg/dL, 95% CI 6.47, 28.21; p = 0.0018) and the evening meal (16.19 mg/dL, 95% CI 5.04, 27.34; p = 0.0045). In the insulin-experienced group, the postprandial SMBG increment was significantly greater in the Asian versus non-Asian subgroup at breakfast (estimated difference 13.81 mg/dL, 95% CI 9.19, 18.44; p < 0.0001) and lunch (29.18 mg/dL, 95% CI 24.22, 34.14; p < 0.0001), but not significantly different at the evening meal. CONCLUSION: In this post hoc analysis, baseline PPG increments were significantly greater in Asian participants with T2D than in their non-Asian counterparts at all mealtimes, with the exception of the evening meal in insulin-experienced participants. Asian adults with T2D may benefit from the use of regimens that control PPG excursions. CLINICAL TRIAL NUMBERS: NCT02762578, NCT01814137, NCT01513590, NCT01009580, NCT01713530, NCT02648217, NCT01045447, NCT01365507, NCT01045707, NCT01272193, NCT01059812, NCT01680341, NCT02906917. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13300-021-01196-7. Springer Healthcare 2022-01-19 2022-02 /pmc/articles/PMC8873325/ /pubmed/35044568 http://dx.doi.org/10.1007/s13300-021-01196-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Yang, Wenying
Akhtar, Shahid
Franek, Edward
Haluzík, Martin
Hirose, Takahisa
Kalyanam, Balamurali
Kar, Soumitra
Wu, Ted
Gogas Yavuz, Dilek
Unnikrishnan, Ambika Gopalakrishnan
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
title Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
title_full Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
title_fullStr Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
title_full_unstemmed Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
title_short Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
title_sort postprandial glucose excursions in asian versus non-asian patients with type 2 diabetes: a post hoc analysis of baseline data from phase 3 randomised controlled trials of idegasp
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873325/
https://www.ncbi.nlm.nih.gov/pubmed/35044568
http://dx.doi.org/10.1007/s13300-021-01196-7
work_keys_str_mv AT yangwenying postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp
AT akhtarshahid postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp
AT franekedward postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp
AT haluzikmartin postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp
AT hirosetakahisa postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp
AT kalyanambalamurali postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp
AT karsoumitra postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp
AT wuted postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp
AT gogasyavuzdilek postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp
AT unnikrishnanambikagopalakrishnan postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp